JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 5 No. 9 675-680
© 1964 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamburger, J. I.
Right arrow Articles by Sills, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamburger, J. I.
Right arrow Articles by Sills, R.

I131 Therapy For Hyperthyroidism: A Plea for Less Conservatism in Complicated Cases1

Joel I. Hamburger, M.D., George Kadian, M.D., Herbert W. Rossin, M.D. and Richard Sills, M.D.

Southland, Michigan

ABSTRACT

1. Where a prolonged hyperthyroid state would constitute a special hazard, consideration should be given to therapy with large doses of I131. A dose twice that usually employed is suggested for diffuse hyperthyroidism. In patients with autonomous hyperfunctioning nodules a dose adequate to deliver 15 – 20 mc I131 to the nodule is employed.
2. Post I131 hypothyroidism, if anticipated and promptly treated, is a relatively minor therapeutic problem, causing only insignificant inconvenience and expense to the patient.
3. Prolonged hyperthyroidism may be lethal in the elderly, the debilitated and the thyrocardiac.

FOOTNOTES

1 Northland Radioisotope Laboratory, Southfield, Michigan.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1964 by the Society of Nuclear Medicine.